This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Scintomics Gmbh, Technical University of Munich. Active years: 2025.
Company Filing History:
1 out of 42 
1 out of 1 
1 out of 152 
Years Active: 2025
Title: Tessa Buckle: Innovator in Targeted Cancer Imaging and Treatment
Introduction
Tessa Buckle is a prominent inventor based in Leiden, Netherlands. She has made significant contributions to the field of medical imaging and cancer treatment through her innovative work. Her research focuses on developing advanced compounds for targeted cancer therapies.
Latest Patents
Tessa Buckle holds a patent for her invention titled "Hybrid tracers for targeted cancer imaging and treatment." This invention relates to compounds of formula I or Ia, where Y is EuK, —EuAF, —EuPG, or -L-EuE, and Z is a chelating moiety. The patent also includes formulations comprising such compounds, as well as methods for imaging or treating cancer using these compounds or formulations. This groundbreaking work has the potential to enhance the effectiveness of cancer diagnostics and therapies.
Career Highlights
Throughout her career, Tessa has worked with notable institutions, including Academisch Ziekenhuis Leiden, also known as LUMC, and Scintomics GmbH. Her experience in these organizations has allowed her to develop her expertise in medical imaging and cancer treatment.
Collaborations
Tessa has collaborated with esteemed colleagues such as Fijs W B Van Leeuwen and Hans-Jurgen Wester. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Tessa Buckle is a trailblazer in the field of targeted cancer imaging and treatment, with her patent showcasing her commitment to improving cancer care. Her work continues to inspire advancements in medical technology and patient outcomes.